These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 2572403

  • 1. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K.
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA.
    Acta Gastroenterol Belg; 1987 Sep; 50(5):555-9. PubMed ID: 2902723
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W, Hartmann F.
    Verh Dtsch Ges Inn Med; 1989 Sep; 95():322-6. PubMed ID: 2574922
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
    Dreyling KW, Hoppe U, Peskar BA, Schaarschmidt K, Peskar BM.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Sep; 17A():339-43. PubMed ID: 2889333
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease].
    Nielsen OH, Ahnfelt-Rønne I.
    Ugeskr Laeger; 1992 Sep 14; 154(38):2544-6. PubMed ID: 1357806
    [No Abstract] [Full Text] [Related]

  • 16. Which 5-ASA?
    Travis SP.
    Gut; 2002 Oct 14; 51(4):548-9. PubMed ID: 12235078
    [No Abstract] [Full Text] [Related]

  • 17. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
    Fahrländer H.
    Schweiz Med Wochenschr; 1987 Oct 17; 117(42):1620-3. PubMed ID: 3321418
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Oct 17; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 20. Will there be a next generation of sulfasalazine?
    Goldman P.
    Gastroenterology; 1982 Nov 17; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.